EUVIMEDEUVIMED entdecken
Crossref

Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects

Min Li, Ying Xie, Jincheng Zhang, Xue Zhou, Lei Gao, Mengmeng He, Xianmei Liu, Xinyi Miao, Yu Liu, Rong Cao, Yi Jia, Zhu Zeng und 1 weitere

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Min Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Cellular Immunotherapy of Guizhou Province, Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Pr…. Hauptthemen laut MEDLINE: Survivin, STAT3 Transcription Factor, Mice, Inbred BALB C, RNA, Messenger. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Guizhou Province, National College Students Innovation and Entrepreneurship Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intratumoral delivery of mRNA encoding immunostimulatory molecules can initiate a robust, global antitumor response with little side effects by enhancing local antigen presentation in the tumor and the tumor draining lymph node. Neoantigen-based mRNA nanovaccine can inhibit melanoma growth in mice by intratumoral injection. Myeloid-derived suppressor cells (MDSCs) suppress antitumor immune responses by secreting immunosuppressive agents, such as reactive oxygen species (ROS). Suppression of STAT3 activity by stattic may reduce MDSC-mediated immunosuppression in the TME and promote the antitumor immune responses. In this study, in vitro transcribed mRNA encoding tumor antigen survivin was prepared and injected intratumorally in BALB/c mice bearing subcutaneous colon cancer tumors. In vivo studies demonstrated that intratumoral survivin mRNA therapy could induce antitumor T cell response and inhibit tumor growth of colon cancer. Depletion of CD8+ T cells could significantly inhibit survivin mRNA-induced antitumor effects. RT-qPCR and ELISA analysis indicated that survivin mRNA treatment led to increased expression of receptor activator nuclear factor-κB ligand (RANKL). In vitro experiment showed that MDSCs could be induced from mouse bone marrow cells by RANKL and RANKL-induced MDSCs could produce high level of ROS. STAT3 inhibitor stattic suppressed activation of STAT3 and NF-κB signals, thereby inhibiting expansion of RANKL-induced MDSCs. Combination therapy of survivin mRNA and stattic could significantly enhance antitumor T cell response, improve long-term survival and reduce immunosuppressive tumor microenvironment compared to each monotherapy. In addition, combined therapy resulted in a significantly reduced level of tumor cell proliferation and an obviously increased level of tumor cell apoptosis in CT26 colon cancer-bearing mice, which could be conducive to inhibit the tumor growth and lead to immune responses to released tumor-associated antigens. These studies explored intratumoral mRNA therapy and mRNA-based combined therapy to treat colon cancer and provide a new idea for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SurvivinSTAT3 Transcription FactorMice, Inbred BALB CRNA, MessengerColonic NeoplasmsCyclic S-OxidesAnimalsCell Line, TumorInjections, IntralesionalMyeloid-Derived Suppressor CellsTumor MicroenvironmentMiceFemaleReactive Oxygen SpeciesCD8-Positive T-LymphocytesCell ProliferationInhibitor of Apoptosis ProteinsHumansTumor BurdenSignal Transduction

Stichwörter der Autor:innen

Colon cancerCombined therapyIntratumoral mRNA therapySTAT3 inhibitor stattic

Substanzen

SurvivinSTAT3 Transcription FactorRNA, MessengerstatticCyclic S-OxidesBirc5 protein, mouseStat3 protein, mouseReactive Oxygen SpeciesInhibitor of Apoptosis Proteins

Autor:innen und Institutionen

  • Engineering Research Center of Cellular Immunotherapy of Guizhou Province, Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, School of Basic Medical Science/School of Biology and Engineer…

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Program of Guizhou Province
  • National College Students Innovation and Entrepreneurship Training Program

Zitieren

APA

Li, M., Xie, Y., Zhang, J., Zhou, X., Gao, L., He, M., Liu, X., Miao, X., Liu, Y., Cao, R., Jia, Y., Zeng, Z., & Liu, L. (2024). Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217111

Vancouver

Li M, Xie Y, Zhang J, Zhou X, Gao L, He M, et al. Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217111

BibTeX
@article{Li2024,
  author = {Li, Min and Xie, Ying and Zhang, Jincheng and Zhou, Xue and Gao, Lei and He, Mengmeng and Liu, Xianmei and Miao, Xinyi and Liu, Yu and Cao, Rong and Jia, Yi and Zeng, Zhu and Liu, Lina},
  title = {Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217111}
}
Kostenlos starten →